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Urinary tract infections (UTI) are one of the most prevalent infections. A rapid and reliable 
screening method is useful to screen out negative samples. The objective of this study 
was to validate the Sysmex flow cytometer UF-1000i by evaluating its accuracy, linearity 
and carry-over; and define an optimal cut-off value to be used in routine practice in our 
hospital. For the validation of the UF-1000i cytometer, precision, linearity and carry-over 
were studied in samples with different counts of bacteria, leukocytes and erythrocytes. 
Between March and June 2016, urine samples were tested in the Clinical Microbiology 
Laboratory at University Miguel Servet Hospital, in Spain. Samples were analyzed with the 
Sysmex UF-1000i cytometer, and cultured. Growth of ≥105 CFUs/mL was considered 
positive. The validation study reveals that the precision in all the variables is acceptable; 
that there is a good linearity in the dilutions performed, obtaining values almost identical 
to those theoretically expected; and for the carry-over has practically null values. A total 
of 1,220 urine specimens were included, of which 213 (17.4%) were culture positive. The 
optimal cut-off point of the bacteria–leukocyte combination was 138.8 bacteria or 119.8 
leukocytes with an S and E of 95.3 and 70.4%, respectively. The UF-1000i cytometer is 
a valuable method to screen urine samples to effectively rule out UTI and, may contribute 
to the reduction of unnecessary urine cultures.
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InTRoDUcTIon
Urinary tract infections (UTIs) are the most common bacterial infections (1–3). However, 70–80% of 
cultures are negative (4–6). Escherichia coli is the most prevalent uropathogen (7) and is responsible 
for approximately 80% of uncomplicated community-acquired UTI (8).
Quantitative urine culture and identification are still the “gold standard” laboratory procedures for 
definitive diagnosis of urinary tract infections, but it is labour-intensive, time-consuming and does 
not provide same-day results (3, 9–15). Therefore, a rapid and reliable screening method is useful to 
screen out negative samples, in order to reduce the overall turnaround time of analyses, workload and 
costs (12, 16). To prevent positive urine samples from erroneously being classified as negative and not 
being cultured, a high sensitivity and negative predictive value (NPV) are prerequisites for a screening 
method (14, 17). The European Urinalysis Guidelines recommend an analytical sensitivity >90–95% 
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to detect asymptomatic bacteriuria at 108 colony-forming bacteria/
litre (CFB/L), equivalent to 105 colony-forming unit (CFU)/mil-
lilitre (mL), by a rapid non-culture method, with a confirmatory 
culture of positive cases (18).
Flow cytometry analysis has long been recognized as capable 
of identifying bacteria (19) and the Sysmex UF-1000i automated 
urine particle flow cytometer has been developed to standardize 
urine sediment analysis. This automated analyser rapidly quanti-
fies urine particles, including white blood cells (WBCs), bacteria, 
red blood cells (RBCs), and casts by scattering and fluorescence (after 
staining) (12). This instrument has a separate measurement chan-
nel for bacteria that improves the specificity for counting bacterial 
organisms (13, 15). Previous studies have demonstrated that this 
system has good precision with low interference, low carryover 
contamination (11). The use of urine flow cytometry and the intro-
duction of a cut-off value, which determines if urine is subsequently 
cultured or not, can reduce the number of cultures (12).
The aim of this study was to validate the Sysmex UF-1000i flow 
cytometer by the evaluation of its precision, linear estimation of 
results and carry-over contamination rate, the comparison of its 
performance to bacterial culture and define a cut-off value to be 
used in routine practice in our hospital.
MATeRIAlS AnD MeThoDS
Testing of precision, linearity  
and carry-over of the UF-1000i
Precision
The within-run precision was determined by measuring the 
RBCs, WBCs, casts, bacteria, and epithelial cells in five samples. 
Each sample was continuously examined 10 times. The results 
of the examinations were recorded and analysed using the coef-
ficient of variation (CV). The point where the CV exceeded 40% 
was arbitrarily defined as the lower limit of quantification.
Linearity
Three high-value urine samples with values close to the expected 
upper limit (RBCs, 10,967/μL; WBCs, 5,100/μL) were selected 
and diluted at ratios of 1:4, 1:16, 1:64, 1:256 and 1:1,024 in negative 
urine (all indexes near 0). The measured values were compared 
with the theoretical values, and the correlation coefficient was 
used to estimate Pearson linear correlation.
Carry-Over
Carry-over was determined by measuring a sample with high-value 
counts in triplicate (H1, H2, H3), followed by three consecutive 
measurements of a sample with low values (L1, L2, L3). Carry-
over was calculated as follows: [(L1 − L3)/(H3 − L3)] × 100%. 
It was established that there is no substantial carry-over when 
this is less than 1%.
collection of Urine Specimens for culture
Between March and June 2016, a total of 1,220 urine samples 
from inpatients and outpatients were tested in the Clinical 
Microbiology Laboratory at University Miguel Servet Hospital, in 
Spain. Sample size was determined by PASS v13 (NCSS Statistical 
Software) based in the Lin and Fine method, using a 95% of 
sensitivity and a precision of 5% for the expected UTI prevalence 
in our population. This study was approved by the local ethics 
committee (Comité de Ética de la Investigación de la Comunidad 
de Aragón (CEICA), reference number: 07/2016).
All urine specimens included in this study were tested by 
culture and UF-1000i cytometer analyser within 24 h of collec-
tion from Tuesday to Friday each week. Samples were excluded 
from analysis if excessive mucus, gross haemolysis or pyuria were 
noted upon visual inspection, or if inadequate sample volume 
(<8 mL) was available to prevent blockage of the instrument or 
interference during the measurement.
Urine culture
Prior to flow cytometry, the urine specimens were cultured 
using a WASP®DT: Walk-Away Specimen Processor (Copan 
Diagnostics, Murrieta, CA, USA) on Brilliance UTI agar (Oxoid 
Ltd., Basingstoke, United Kingdom). Cultures were incubated at 
35°C for 18–24 h. Bacterial counts were expressed as the number of 
colony-forming units per millilitre. Growth of ≥105 CFUs/mL was 
considered positive. Grown colonies were identified by MALDI-
TOF (MALDI Microflex LT, Bruker Daltonics, Bremen, Germany). 
If there were three or more types of colonies without a dominant 
species, the urine culture was considered as contaminated but clas-
sified as negative and not subjected to the identification procedure.
Urinalysis
After culture, the urine specimens were analysed in the Sysmex 
UF-1000i flow cytometer. The UF-1000i is a urine flow cytom-
eter that uses a diode laser to quantify sediment in two analytic 
channels, and a fluorescent dye which stains DNA. One channel 
analyses only the microbial contents of the urine, while the other 
analyses RBCs, WBCs, casts and other non-microbial sediment. 
The staining agent is a fluorescent polymethine dye that binds to 
DNA. After staining, the particles are transported to a flow cell 
and are irradiated by a semiconducting laser (λ 635 nm). Forward 
scatter, side scatter, and fluorescence intensities of the individual 
particles are detected and information about particle size and 
structure is shown, which drives to identify and count the par-
ticles. The results are presented in histograms and scattergrams.
Data Analysis
Statistical analysis was carried out by NCSS v10 and StatR v3.3.1. 
The correlation coefficient was used to estimate the linear cor-
relation of theoretical vs. actual counts of RBCs and WBCs as 
measured by the UF-1000i. A ROC curve to determine the best 
cut-off values for bacteria and WBCs were calculated. Positive 
predictive value (PPV), NPV and accuracy rate at the best cut-off 
values for bacteria and WBCs were also calculated considering 
the urine culture as the reference.
ReSUlTS
Sysmex UF-1000i Technical Validation
Precision
Precision of the UF-1000i in identifying the five formed compo-
nents in urine is provided in Table 1. The intervals of the CV was 
presented in each component: RBCs 7.5–13.5% (19.34–10.84/μL); 
TAble 1 | Precision of the UF-1000i.
Sample 
1
Sample 
2
Sample 
3
Sample 
4
Sample 
5
RBC Average 12.43 22.57 19.34 10.84 6.25
CV (%) 10.2 13.3 7.5 13.5 10.1
WBC Average 1.46 5.65 1.14 6.83 12.57
CV (%) 24.6 18.5 31.8 18.9 13.5
EC Average 1.11 22.16 1.11 7.14 10.4
CV (%) 27.7 9.0 34.6 14.1 13.4
CAST Average 0.121 0.402 0.052 0.295 0.416
CV (%) 152.9 74.3 129.1 60.4 67.6
BACTERIA Average 1.62 8.18 1.98 46.71 632.83
CV (%) 98.8 29.7 82.4 18.6 2.8
RBC, red blood cells; WBC, white blood cells; EC, epithelial cells; CV, coefficient of 
variation.
0
FIgURe 1 | Scatter diagram of obtained and theoretical white blood cell 
(WBC) in sample 1.
FIgURe 2 | Scatter diagram of obtained and theoretical white blood cell 
(WBC) in sample 2.
FIgURe 3 | Scatter diagram of obtained and theoretical white blood cell 
(WBC) in sample 3.
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WBCs 13.5–31.8% (12.57–1.14/μL); bacteria high-value counts 
2.8–29.7% (8.2–632.8/μL); bacteria low value counts 82.4–98.8% 
(1.6–2.0/μL); epithelial cell 9.0–34.6% (22.16–1.11/μL); and casts 
60.4–152.9% (0.29–0.12/μL). The precision in all variables is 
acceptable, with values below the limit of 40%, except in CAST 
and low value counts of bacteria. In these cases, the average 
number of cylinders and bacteria in urine of all samples analysed 
is close to 0, which leads to a mathematical artefact with an exces-
sively high CV.
Linearity
Linearity results were good for WBC (R2 = 1 sample 1, R2 = 0.99 
sample 2, R2 =  0.99 sample 3) (Figures  1–3), RBC (R2 =  0.99 
sample 1, R2 = 1 sample 2, R2 = 0.99 sample 3) (Figures 4–6) and 
bacteria (R2 = 1 sample 1, R2 = 0.19 sample 2, R2 = 0.99 sample 3) 
on the UF-1000i (Figures  7–9). In sample 2, no linearity was 
found in bacteria since there was a very low initial value. Globally, 
it can be concluded that there is good linearity in the dilutions 
performed, obtaining in the UF-1000i analyser values almost 
identical to those expected theoretically.
Carry-Over
The carry-over contamination rates of RBCs, WBCs and bacteria 
were 0.2, 0.0 and 0.0%, respectively. The results showed that 
UF-1000i has practically null carry-over values.
Screening of Significant bacteriuria
A total of 1,220 urine specimens were included, of which 213 
(17.4%) were culture positive (>105  CFUs/mL urine) and 1,007 
FIgURe 4 | Scatter diagram of obtained and theoretical RBC in sample 1.
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(82.6%) were culture negative. The majority of the specimens were 
collected from women (58.4%). The mean ages for men and women 
were 56.65 years (SD 23) and 44.96 years (SD 25.7), respectively. 
Outpatients represented 53.3% (n =  650) and inpatients 46.7% 
(n =  570) of the subjects. The most common microorganisms 
identified were Escherichia coli (62%), Enterococcus faecalis (9.4%), 
Klebsiella pneumoniae (7%), coagulase-negative Staphylococcus 
(5.6%), Proteus mirabilis (3.3%), Enterobacter cloacae (2.8%), 
Pseudomonas aeruginosa (2.8%), Streptococcus agalactiae (2.3%), 
Citrobacter freundii (0.9%), Klebsiella oxytoca (0.9%), Streptococcus 
oralis (0.9%), Enterobacter aerogenes (0.5%), Enterococcus faecium 
(0.5%), Proteus vulgaris (0.5%) and Candida albicans (0.5%).
Ten samples were found to be culture-positive and the Sysmex 
UF-1000i negative (false-negatives, 0.8%) at a cut-off value of 
138.8 bacteria/μL or 119.8 leukocyte/μL. The culture results for 
these ten samples were: P. mirabilis (three); C. albicans (one); 
P. vulgaris (one); E. faecalis (one); E. coli (one); P. aeruginosa 
(one); S. epidermidis (one); and S. agalactiae (one).
A ROC curve analysis was performed to assess the diagnos-
tic value of bacteria and leukocyte count from flow cytometry 
(Figure 10). Overall, bacteria [area under the curve (AUC) 0.943] 
performed better than WBCs (AUC 0.832) as a predictor of cul-
ture results. For dipstick analysis, sensitivity (SE), specificity (SP), 
NPV, and PPV at different possible cut-off values were calculated 
(Table 2). The most balanced cut-off value was 89.4 bacteria/μL 
for bacteria, with sensitivity, specificity and NPVs of 94.8, 69.2 
and 99.4%, respectively. The most balanced cut-off value was 3.8 
FIgURe 5 | Scatter diagram of obtained and theoretical RBC in sample 2.
FIgURe 6 | Scatter diagram of obtained and theoretical RBC in sample 3.
FIgURe 7 | Scatter diagram of obtained and theoretical bacteria in  
sample 1.
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leukocyte/μL for WBCs, with sensitivity, specificity and NPVs of 
94.8, 36.7 and 97.1%, respectively.
Finally, we evaluated the effect of gender on UF-1000i per-
formance for detecting >105  CFUs/mL bacterial growth. The 
ROC AUCs were 0.956 and 0.946 (bacteria) and 0.876 and 0.798 
(WBC) for men and women, respectively (Figures 11 and 12). 
The optimized cut-offs were 31.3 and 159.3 bacteria/μL and 3.9 
and 3.8 WBC/μL, for men and women, respectively. Resulting SE, 
SP, PPV and NPV are listed in Table 2.
In the combined model using a bacteria or WBC cut-off together 
(138.8 bacteria/μL–119.8 leukocyte/μL), performance (SE = 95.3%, 
SP = 70.4%) was better than bacteria or leukocyte alone (Table 3).
DIScUSSIon
Urine is the most frequently received sample in the clinical 
microbiology laboratory and bacteria culture detection remains 
the gold standard technique for diagnosis of UTI. However, this 
method is time consuming and often unnecessarily applied to 
negative samples (3). A clinically useful screening method for 
UTI should be rapid, inexpensive, easy to perform and must 
have the highest values of sensitivity and NPV (3, 10, 16, 20). 
It is also important that there are no false-negatives, especially in 
immunosuppressed and elderly patients because of the severity 
of urinary sepsis. On the other hand, a high number of false posi-
tives should not be tolerated either because of the consequences 
of unnecessary antibiotic treatment or because of the presence 
of bacteria from the usual Gram-positive flora and even of over-
treated bacteria that would be exposed to resistance mechanisms 
surviving in small clusters until the following UTI. The UF-1000i 
analyser has an analytic channel with specific reagent system 
exclusively dedicated for bacteria quantification, which has 
enhanced both SE and SP (21).
In this study, the results of the UF-1000i performance evaluation 
showed that this instrument has good precision and accuracy, and 
carryover was negligible. These results agree with previous studies, 
which have demonstrated that these systems have good precision 
with low interference, low carryover contamination, and are con-
sistent with microscopic counting results (22–24). These advantages 
make the UF-1000i a promising screening platform for UTI (11).
We evaluated the performance of the Sysmex UF1000i in 
comparison with the urine culture method for screening urine 
samples for UTI. We established the optimum cut-off values 
for bacteria and leucocytes in our setting for the diagnosis of 
FIgURe 8 | Scatter diagram of obtained and theoretical bacteria in  
sample 2.
FIgURe 10 | ROC curve analysis for general population. The area under the 
curve (AUC) is 0.943 for bacterial count and 0.832 for leukocyte count by 
flow cytometry, using urine culture as the reference method.
FIgURe 9 | Scatter diagram of obtained and theoretical bacteria in  
sample 3.
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FIgURe 12 | ROC curve analysis for women. The area under the curve 
(AUC) is 0.946 for bacterial count and 0.798 for leukocyte count by flow 
cytometry, using culture as the reference method.
TAble 2 | Performance of the Sysmex® UF-1000i at different cut-off thresholds for leukocyte and bacteria counts.
group Area under 
the curve
cut-off Sensitivity (%) Specificity (%) positive predictive 
value (%)
negative predictive 
value (%)
General population Bacteria 0.943 89.4 94.8 69.2 39.5 98.4
255.3 90.1 79.6 48.8 97.4
White blood cell (WBC) 0.832 3.8 94.8 36.7 24.1 97.1
6.3 90.1 51.0 28.0 96.1
Men Bacteria 0.956 31.3 94.9 78.3 44.6 98.8
89.4 89.9 90.0 62.3 98.0
WBC 0.876 3.9 94.9 44.3 23.9 97.9
14.1 89.9 73.0 38.0 97.5
Women Bacteria 0.946 159.3 94.8 60.9 36.0 98.1
687.2 90.3 82.9 55.0 97.4
WBC 0.798 3.8 94.8 32.0 24.4 96.4
6.3 90.3 46.2 28.0 95.4
bacteriuria, assuming a cut-off >105 CFU/mL as significant bac-
teriuria for culture test. The definition of positive urine cultures 
is still a matter of debate (3), De Rosa et al. (10) and Marschal 
et al. (25) consider 104 and 102 CFU/mL as significant bacteriuria, 
respectively. Possible false-negative cultures could be caused by 
the presence of dead bacteria in the urine due to treatment or a 
low bacterial load. In addition, we determined gender-dependent 
cut-off values for flow cytometric screening of urine samples.
The prevalence of UTIs in our study was 17.4% and the 
organisms identified were similar to those reported in literature 
(16, 26). The percentage of false-negatives in urine screening in 
this study was 0.8%, similar to that obtained by other authors 
(10, 22), which is around 1%. We found 10 false-negative 
results; three of which were P. mirabilis and only one was E. 
faecalis. False-negative results with Gram-negatives have been 
documented with the use of the Sysmex UF-1000i (10, 17, 21, 
27, 28). However, other studies report false-negatives in UTIs 
due to Enterococcus spp. and S. aureus (21, 22, 25, 29), which 
should be ascribed to phenomena of aggregation of bacterial 
cells (14, 21).
The European Urinalysis Guidelines recommend an analytical 
sensitivity >90–95% to detect bacteriuria at 105  CFU/mL by a 
rapid non-culture method with a confirmatory culture of positive 
cases (18, 28, 30). For a rule-out strategy, the cut-off point deter-
mination is a difficult task, as increasing test sensitivity decreases 
its specificity. ROC analysis is a commonly used method for 
FIgURe 11 | ROC curve analysis for men. The area under the curve (AUC) is 
0.956 for bacterial count and 0.876 for leukocyte count by flow cytometry, 
using culture as the reference method.
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determination of cut-off points at which optimal sensitivity and 
specificity are achieved for clinical use.
There is a great diversity of opinion in the cut-off point chosen 
as the most optimal to apply in the Sysmex UF-1000i system. 
According to the literature, it ranges from 25 to 230 bacteria/μL 
(10, 13, 21, 22, 29, 31). In our study, we have established an opti-
mal cut-off point of 89.4 bacteria/μL, with sensitivity of 94.8% 
and specificity of 69.2% for positive cultures >105 CFU/mL urine. 
Our results were comparable to figures reported by previous 
evaluation studies of the Sysmex UF-1000i. For example, Giesen 
et al. (32) reported cut-off values of 288.9 bacteria/μL urine or 
31.8 leukocyte/μL for positive cultures >105 CFU/mL urine lead-
ing to an SE of 93 and 89% and SP of 86 and 79%, respectively. 
In addition, March-Rosselló et al. (28) found an SE of 87.2% and 
SP of 85.2% with cut-off values of 247  bacteria/μL urine and SE 
of 70.9% and SP of73.7% with cut-off values of 31.8  leukocytes/μL 
urine for bacterial cultures >105 CFU/mL urine. On the contrary, 
other studies report on significantly better results as Manoni et al. 
(21) that reported a cut-off value of 125 bacteria/μL urine with 
a sensitivity of 97% and a specificity of 94% (considering posi-
tive cultures >105 CFU/mL urine). They also reported a cut-off 
value of 40 leukocytes/μL urine with an 87 and 79% of SE and SP. 
In addition, Martín-Gutiérrez et al. (27) found an SE of 99.1% 
and SP of 91.5% with cut-off values of 200  bacteria/μL urine 
for bacterial cultures >105 CFU/mL urine. The different patient 
population studied can explain this seemingly contradictory 
finding. The differences between these studies and our might be 
due to on divergent study designs.
There is no agreement on the usefulness of leukocyte counts 
as a parameter to discriminate between positive and negative 
urine. In some studies that took into account an improvement in 
operational characteristics (10, 21, 22, 28). Our results agree with 
these studies. In other cases, leukocyte counts did not improve 
the operational characteristics with respect to those obtained 
with only the bacterial count to discriminate between positive 
and negative urine, so that several authors concluded that they 
should not be considered in screening (14, 28, 31). The Sysmex 
UF-1000i and other systems such as the iQ200 classifies and 
quantifies the particles, including bacteria, yeasts, WBCs, and 
squamous epithelial cells. Nevertheless, no study has evaluated 
in a regressive multifactorial way the presence of epithelial cells as 
a NPV factor, except the study of Russcher et al. (20) comparing it 
with Gram staining and the Q index. Muñoz-Algara et al. evalu-
ated the number of squamous epithelial cells and their relation-
ship with contaminated urine, concluding that they can be a good 
predictor of contamination in urine of women of childbearing age 
(17). Squamous epithelial cells could, therefore, be a parameter 
to consider that would improve the predictive values of UF-1000i 
since samples considered contaminations were not excluded in 
our study.
For several patient groups, the general cut-off value established 
may not be valid, for example for pregnant women, children, 
immunocompromised patients, and patients on antibiotics 
(16). In general, female samples have higher bacterial counts 
than male samples, because of physiological reasons. This could 
partially be resolved by employing a gender-specific cut-off value 
(13). We have evaluated different gender-specific cut-off values, 
the optimized cut-offs were 31.3 and 159.3 bacteria/μL for men 
and women, respectively. Our results agree with the study of 
Jolkkonen et al. (13). These results could vary depending on the 
rate of negative cultures in the laboratory and the features of the 
population selected could influence it. Therefore, it is necessary to 
assess the screening method in different patient populations (20).
In our study, the sensitivity, specificity, and AUC of bacterial 
count in the Sysmex UF-1000i analyser system were higher than 
those of WBC count, and the combination of both counts for UTI 
screening showed sensitivity and NPV improvements to bacte-
rial counts alone, which may help the clinical laboratory filter 
out true-negative samples, improving detection efficiency and 
reducing laboratory costs. In addition, some studies found that 
the NPV could be further improved when the results of WBC 
and bacteria were combined (15, 22). Nevertheless, some articles 
showed the effectiveness of screening with WBC plus bacterial 
counts, with an increase in sensitivity but a decrease in specificity 
(10, 14, 21, 26, 27).
The Sysmex UF1000i could be an interesting tool in other 
diseases. Grosso et al. reported a sensitivity of 84%, a specificity of 
82%, and a high NPV (96%) of The UF1000i for ruling out acute 
non-gonococcal urethritis or predicting the presence of infection 
(33). In addition, the body fluid mode of this technology has been 
evaluated successfully to WBCs count in continuous ambulatory 
peritoneal dialysis, ascites fluids, cerebrospinal fluid and saliva 
in patients with periodontal inflammation with a sensitivity of 
100, 100, 96.6 and 76%, and a specificity 86, 89, 97.4 and 78%, 
respectively (23, 34, 35).
This study shows that flow cytometry is a valuable method to 
screen urine samples to effectively rule out UTI and, may contrib-
ute to the reduction of unnecessary urine cultures. Second, the 
cut-offs set for the Sysmex UF-1000i in the present study allowed 
a reduction in culture tests. These results are important, because 
they allow a reduction in urine culture costs and free up labora-
tory resources for other activities. In addition, the cut-off values 
of bacteria and WBC counts depend on the study population, 
the type of specimens, the selected threshold for the significant 
count in culture, and thus must be investigated and reported by 
each laboratory.
TAble 3 | Performance of the Sysmex® UF-1000i at cut-off for leukocyte and bacteria counts alone and in the combined model using a bacteria or white blood cell 
(WBC) cut-off.
group Area under the 
curve
cut-off Sensitivity (%) Specificity (%) positive predictive 
value (%)
negative predictive 
value (%)
General 
population
Bacteria 0.943 138.8 92.9 73.4 42.5 98.0
WBC 0.832 119.8 51.2 92.5 59.2 89.2
Bac or WBC 138.8–119.8 95.3 70.4 40.5 98.6
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